Next-Generation Sequencing (NGS) and Third-Generation Sequencing (TGS) for the Diagnosis of Thalassemia
Diagnostics · 19.01.2023 · 13 (3) · 373
DOI: 10.3390/diagnostics13030373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 19.01.2023. Verfasst von Syahzuwan Hassan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education, Ministry of Higher Education Malaysia for Fundamental Research.
Abstract (Originalsprache)
Thalassemia is one of the most heterogeneous diseases, with more than a thousand mutation types recorded worldwide. Molecular diagnosis of thalassemia by conventional PCR-based DNA analysis is time- and resource-consuming owing to the phenotype variability, disease complexity, and molecular diagnostic test limitations. Moreover, genetic counseling must be backed-up by an extensive diagnosis of the thalassemia-causing phenotype and the possible genetic modifiers. Data coming from advanced molecular techniques such as targeted sequencing by next-generation sequencing (NGS) and third-generation sequencing (TGS) are more appropriate and valuable for DNA analysis of thalassemia. While NGS is superior at variant calling to TGS thanks to its lower error rates, the longer reads nature of the TGS permits haplotype-phasing that is superior for variant discovery on the homologous genes and CNV calling. The emergence of many cutting-edge machine learning-based bioinformatics tools has improved the accuracy of variant and CNV calling. Constant improvement of these sequencing and bioinformatics will enable precise thalassemia detections, especially for the CNV and the homologous HBA and HBG genes. In conclusion, laboratory transiting from conventional DNA analysis to NGS or TGS and following the guidelines towards a single assay will contribute to a better diagnostics approach of thalassemia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.
- Institute for Medical Research, Shah Alam 40170, Malaysia.
- School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.
ORCID-Profile: Muhammad Farid Johan, Zefarina Zulkafli
Förderung
- Ministry of Higher Education
- Ministry of Higher Education Malaysia for Fundamental Research
Zitieren
APA
Hassan, S., Bahar, R., Johan, M. F., Mohamed Hashim, E. K., Abdullah, W. Z., Esa, E., Abdul Hamid, F. S., & Zulkafli, Z. (2023). Next-Generation Sequencing (NGS) and Third-Generation Sequencing (TGS) for the Diagnosis of Thalassemia. Diagnostics, 13(3), 373. https://doi.org/10.3390/diagnostics13030373
Vancouver
Hassan S, Bahar R, Johan MF, Mohamed Hashim EK, Abdullah WZ, Esa E, et al. Next-Generation Sequencing (NGS) and Third-Generation Sequencing (TGS) for the Diagnosis of Thalassemia. Diagnostics. 2023;13(3):373. doi:10.3390/diagnostics13030373
BibTeX
@article{Hassan2023,
author = {Hassan, Syahzuwan and Bahar, Rosnah and Johan, Muhammad Farid and Mohamed Hashim, Ezzeddin Kamil and Abdullah, Wan Zaidah and Esa, Ezalia and Abdul Hamid, Faidatul Syazlin and Zulkafli, Zefarina},
title = {Next-Generation Sequencing (NGS) and Third-Generation Sequencing (TGS) for the Diagnosis of Thalassemia},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {3},
pages = {373},
doi = {10.3390/diagnostics13030373}
}
EUVIMED